Myotonic Dystrophy Drug Market Revenue 2024 to 2034
Myotonic Dystrophy Drug Market Revenue 2024 to 2034
Myotonic Dystrophy Drug Market: Surging from USD 22.89 Bn in 2024 to USD 112.65 Bn by 2034, at 17.28% CAGR, supported by breakthroughs in rare disease treatments and expanding neurology pipeline.
Report ID: 10451
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 22.89 Bn
Forecast Year,
USD 112.65 Bn
CAGR, 2025 -
17.28%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Myotonic Dystrophy Drug Market Size Analysis
Myotonic Dystrophy Drug Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 7.32 | 8.57 | 10.04 | 11.80 | 13.95 | 16.38 | 19.24 | 22.45 | 26.16 | 30.53 | 35.85 |
| Biologics | 7.78 | 9.15 | 10.74 | 12.57 | 14.69 | 17.19 | 20.13 | 23.73 | 27.89 | 32.69 | 38.10 |
| Advanced Therapies | 4.12 | 4.82 | 5.65 | 6.63 | 7.75 | 9.11 | 10.66 | 12.47 | 14.68 | 17.30 | 20.32 |
| Others | 3.66 | 4.31 | 5.05 | 5.92 | 6.91 | 8.11 | 9.52 | 11.19 | 13.18 | 15.54 | 18.39 |
Myotonic Dystrophy Drug Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 8.24 | 9.67 | 11.31 | 13.21 | 15.50 | 18.13 | 21.28 | 25.03 | 29.26 | 34.28 | 40.05 |
| Cardio-Metabolic | 4.12 | 4.86 | 5.69 | 6.70 | 7.85 | 9.22 | 10.88 | 12.78 | 14.95 | 17.58 | 20.66 |
| Infectious | 3.66 | 4.26 | 4.99 | 5.88 | 6.94 | 8.14 | 9.49 | 11.09 | 13.05 | 15.33 | 18.02 |
| CNS | 3.20 | 3.75 | 4.42 | 5.21 | 6.10 | 7.16 | 8.46 | 9.92 | 11.67 | 13.73 | 16.17 |
| Others | 3.66 | 4.30 | 5.07 | 5.92 | 6.92 | 8.13 | 9.44 | 11.01 | 12.97 | 15.14 | 17.74 |
Myotonic Dystrophy Drug Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 10.07 | 11.74 | 13.77 | 16.10 | 18.80 | 22.01 | 25.82 | 30.39 | 35.73 | 42.06 | 49.22 |
| Retail Pharmacy | 8.24 | 9.69 | 11.38 | 13.37 | 15.74 | 18.51 | 21.73 | 25.40 | 29.67 | 34.62 | 40.60 |
| Online/Other | 4.58 | 5.41 | 6.33 | 7.45 | 8.76 | 10.26 | 12.00 | 14.05 | 16.51 | 19.37 | 22.83 |
Myotonic Dystrophy Drug Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 9.16 | 10.70 | 12.60 | 14.79 | 17.37 | 20.36 | 23.90 | 28.14 | 33.02 | 38.69 | 45.19 |
| Europe | 6.41 | 7.51 | 8.79 | 10.28 | 12.06 | 14.15 | 16.62 | 19.42 | 22.75 | 26.57 | 31.29 |
| Asia Pacific | 5.49 | 6.47 | 7.59 | 8.90 | 10.40 | 12.20 | 14.27 | 16.71 | 19.67 | 23.20 | 27.27 |
| Latin America | 0.92 | 1.07 | 1.25 | 1.47 | 1.74 | 2.05 | 2.40 | 2.82 | 3.27 | 3.84 | 4.50 |
| Middle East & Africa | 0.92 | 1.08 | 1.25 | 1.47 | 1.73 | 2.02 | 2.36 | 2.75 | 3.20 | 3.75 | 4.39 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
